Oral progestagens before menopause and breast cancer risk.
about
Hot flashes in breast cancer survivors and an association with calcium supplement use.Tracking progesterone receptor-mediated actions in breast cancerProgestin and breast cancer risk: a systematic review.Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.Biological measures to minimize the risk of radiotherapy-associated second cancer: A research perspective.Dienogest and the breast.Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.Progestins and medical treatment of endometriosis - physiology, history and society.
P2860
Q34345637-4F38FA53-A7D3-48D8-B8A1-0CED8A558878Q34388848-E760FB7F-EB35-47C8-B180-248EBD0A8CD9Q35877473-C92463EB-EAD4-43EC-A8D6-8F44B3A2C45AQ36936457-4F733283-7789-4B0F-AB47-9FACEAA16D6AQ38769860-FDE79625-E24C-454A-8DE5-1EF81082771DQ45981655-3CF23F5F-FB93-4619-9C65-AD2F4DCF503CQ48212165-1FECF170-BBC7-40C0-B9D5-BF80F82BC885Q48957306-E369177A-5DC9-4148-A7C7-8F4278C0FD52
P2860
Oral progestagens before menopause and breast cancer risk.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oral progestagens before menopause and breast cancer risk.
@ast
Oral progestagens before menopause and breast cancer risk.
@en
type
label
Oral progestagens before menopause and breast cancer risk.
@ast
Oral progestagens before menopause and breast cancer risk.
@en
prefLabel
Oral progestagens before menopause and breast cancer risk.
@ast
Oral progestagens before menopause and breast cancer risk.
@en
P2093
P2860
P356
P1476
Oral progestagens before menopause and breast cancer risk.
@en
P2093
F Clavel-Chapelon
M-C Boutron-Ruault
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603618
P407
P577
2007-02-13T00:00:00Z